Therapeutic Drug Monitoring of Sunitinib in Gastrointestinal Stromal Tumors and Metastatic Renal Cell Carcinoma in Adults—A Review

Conclusions: According to the current evidence presented in this review, a TDM-guided dose modification of sunitinib in selected groups of patients could provide a better treatment outcome while simultaneously preventing sunitinib toxicity.
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Focus Series: TDM in Oncology Source Type: research